BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ
17.26
+0.29(+1.71%)
  • Volume:
    3,226,395
  • Bid/Ask:
    17.18/17.34
  • Day's Range:
    16.76 - 17.61

BCRX Overview

Prev. Close
16.97
Day's Range
16.76-17.61
Revenue
32.05M
Open
17.09
52 wk Range
3.31-17.73
EPS
-1.21
Volume
3,226,395
Market Cap
3.07B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,274,066
P/E Ratio
-
Beta
2.58
1-Year Change
287.87%
Shares Outstanding
177,696,474
Next Earnings Date
Aug 05, 2021
What is your sentiment on BioCryst Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

BioCryst Pharmaceuticals Inc News

BioCryst Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsSellStrong SellStrong BuyStrong BuyStrong Buy
SummarySellSellStrong BuyStrong BuyStrong Buy

BioCryst Pharmaceuticals Inc Company Profile

BioCryst Pharmaceuticals Inc Company Profile

Employees
246

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase I clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. BioCryst Pharmaceuticals, Inc. has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Read More
  • Check out HAE INTERNATIONAL WEB SITE very nice.
    0
    • just buy and hold only research you need
      0
      • Just noticed this stock. Really like the latest uptrend. Can anyone justify to me why this stock is undervalued considering it's not making any profit and is only making a few millions in revenue and has a market cap of almost 3B? Thanks in advance, it might spare me the research.
        0
        • here is your research buy and hold
          0
      • BCRX undervalued
        0
        • Apls 5 billion market cap
          0
          • don't sell a single share
            0
            • Holding 7500 shares and options
              0
          • WHAT A GREAT COMPANY!!! BCRX goooo
            0
            • My friend Bene get back to ST
              0
            • it's motleycrue18 😉😉
              0
            • I know :) Hi Gus! :)
              0
          • Evofem Biosciences EVFM Receives Fast Track Designation for EVO100 for Prevention of Gonorrhea in Women
            0
            • All the way up to 70 usd until end of 2022
              0
              • last conference don't forget the plus.
                0
                • 50% market share on Orladeyo
                  0
                  • 500 million plus according to Stoney
                    0
                    • Wow cheap shares !! Love the discount
                      0
                      • it's like walking down the clearance aisle..got my shopping cart full..
                        0
                        • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
                          0
                          • this is a bcrx forum. stop spamming.
                            0
                        • Wainwright raises price target to 19 this morning.
                          0
                          • It's like playing with a stick of dynamite.
                            0
                            • This company can cure covid and now diabetes I would not want to be short.
                              0
                              • Which is exciting and why I believe in biocryst but kind of a double edged sword yeah? Being that big pharm like phiiizer and Modernaa and j&jj DON'T want them to succeed... But with that said 💎🤲
                                0
                              • Which is exciting and why I believe in biocryst but kind of a double edged sword yeah? Being that big pharm like phiiizer and Modernaa and j&jj DON'T want them to succeed... But with that said 💎🤲
                                0
                            • I'll buy at 7
                              1
                              • maybe in another life... compà
                                0
                            • easily worth 30+, bought more on yesterday's dip...good new and stock going down...I'll keep buying!!
                              0
                              • with this much power this stock will jump to 15 in a flash I just double my position I trust this company and it will only make sense if this dip was for us to even get a better chance for what is coming 😉
                                0
                                • I'll buy at 10 dollars
                                  2
                                  • i know you from you spamming gme
                                    0
                                • someone is loading big time for this to happen never seen a dip like this especially on a big day like today BCRX is all over the news and great news and this happen unbelievable 👏
                                  0
                                  • accumulate when you can
                                    0
                                    • Edwin just enjoy the ride
                                      0
                                      • thanks bruce
                                        0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.